Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models
Nature Medicine2018Vol. 24(2), pp. 194–202
Citations Over TimeTop 1% of 2018 papers
M. Schulte, Allie Fu, Ping Zhao, Jun Li, Ling Geng, Shannon T. Smith, Jumpei Kondo, Robert J. Coffey, Marc O. Johnson, Jeffrey C. Rathmell, Joe T. Sharick, Melissa C. Skala, Jarrod A. Smith, Jordan Berlin, M. Kay Washington, Michael L. Nickels, H. Charles Manning
Related Papers
- → Response of glutamine metabolism to glutamine-supplemented parenteral nutrition(2000)49 cited
- → Glutamine as an Immunoenhancing Nutrient(1999)47 cited
- → Glutamate and CO2 production from glutamine in incubated enterocytes of adult and very old rats(2012)9 cited
- → Glutamine Content of Whole Proteins: Implications for Enteral Formulas(1992)35 cited
- → The Effect of Glutamine Administration on Intestinal Glutamine Content(1996)36 cited